Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
// YihHuei Uen 1, 2, 3 , Jin-Wun Wang 4 , ChiaChen Wang 5, 6 , Yaoyun Jhang 5 , Jo-Yun Chung 5 , TingTing Tseng 5 , MingJen Sheu 7 and ShaoChen Lee 5 1 Department of Surgery, ChiMei Hospital, Chiali, Jiali Dist., Tainan City, Taiwan 2 Department of Surgery, Asia University Hospital, Taichung City, Taiwan 3 Department of Biotechnology, Asia University, Taichung City, Taiwan 4 Department of Surgery, ChiMei Hospital, Chiali, Jiali Dist., Tainan City, Taiwan 5 School of Medicine, Fu Jen Catholic University, Xinzhuang Dist., New Taipei City, Taiwan 6 Department of Dermatology, Cardinal Tien Hospital, Xindian Dist., New Taipei City, Taiwan 7 Department of Hepato-Gastroenterology, ChiMei Hospital, Yongkang Dist., Tainan City, Taiwan Correspondence to: ShaoChen Lee, email: 073798@mail.fju.edu.tw Keywords: microRNA; syndecan-1; breast cancer; exosome Received: November 14, 2016 Accepted: May 24, 2018 Published: June 15, 2018 ABSTRACT MicroRNAs are small noncoding RNAs acting as novel biomarkers of various diseases and potential regulators of protein expression and functions. Syndecan-1 is the heparan sulfate proteoglycan associated with malignancy of various cancers, including breast cancer. In this study, we proposed a experimental workflow to investigate potential microRNAs that regulate SDC1 expression and affect breast cancer cell mobility. MicroRNA candidates were selected from available Gene Expression Omnibus datasets on breast malignancy. Further in silico duplex hybridization and multiplex PCR approach were used to screen potential microRNAs. Analysis showed increased syndecan-1 expression but decreased miR-122-5p level upon breast malignancy. Western blot and in vitro luciferase assay confirmed the targeting of 3′-untranslated region of syndecan-1 and suppression of syndecan-1 expression by miR-122-5p. The suppression of syndecan-1 expression by miR-122-5p or shRNAs against syndecan-1 increased breast cancer cell mobility; while overexpression of syndecan-1 inhibited cell mobility. In further, miR-122-5p was enriched in liver cell-derived exosomes that was able to suppress syndecan-1 expression and increase cell mobility in breast cancer cells. In conclusion, our results suggested the downregulation of SDC1 by miR-122-5p or liver-cell-derived exosomes would enhance breast cancer cell mobility. Metastasis or mobility of breast cancer cells might be affected by circulating miR-122-5p and not directly correlated with progression of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lorenz, R., Bernhart, S. H., Höner zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F., & Hofacker, I. L. (2011) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-6-26 · Cited by 5,098 · cited 1×
“Totally, 15 potential miRNAs were found with folding energy of miRNA-target heteroduplex less than −25 kcal/mol as determined by Vienna RNA package [19] (Figure 2A and 2B).”
MethodThe evolution of gene regulation by transcription factors and microRNAs
Chen, K., & Rajewsky, N. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1990 · Cited by 1,547
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118 · cited 1×
“Recent paper indicated that higher level of circulating miR-122 associated with metastasis in breast cancer patients, which was explained by suppression of glucose uptake by niche cells but increase of glucose uptake by breast cancer cells using cancer-cell-secreted miR-122 [34].”
BackgroundTrafficking and function of the tetraspanin CD63
Pols, M. S., & Klumperman, J. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.09.020 · Cited by 745 · cited 4×
“The primary antibody against CD63 and β-actin were obtained from GeneTex Inc., Hsinchu, Taiwan.”
BackgroundInfluentialThe heparanase/syndecan‐1 axis in cancer: mechanisms and therapies
Ramani, V. C., Purushothaman, A., Stewart, M. D., Thompson, C. A., Vlodavsky, I., Au, J. L., & Sanderson, R. D. (2013) · The FEBS Journal · doi:10.1111/febs.12168 · Cited by 189
Cited by
Effect of exosomal miRNA on cancer biology and clinical applications
Sun, Z., Shi, K., Yang, S., Liu, J., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., & Yuan, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0897-7 · Cited by 800
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
Faramin Lashkarian, M., Hashemipour, N., Niaraki, N., Soghala, S., Moradi, A., Sarhangi, S., Hatami, M., Aghaei-Zarch, F., Khosravifar, M., Mohammadzadeh, A., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02868-z · Cited by 105
Metadata
- Authors
- Uen, Y., Wang, J.-W., Wang, C., Jhang, Y., Chung, J.-Y., Tseng, T., Sheu, M., & Lee, S.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2018-06-15
- Volume
- 9
- Issue
- 46
- Pages
- 28165-28175
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2807967001
- Cited by
- 43
- References
- 5
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury. https://app.cochat.ai/papers/10.18632/oncotarget.25589
- The paper
- Uen, Y., Wang, J.-W., Wang, C., Jhang, Y., Chung, J.-Y., Tseng, T., Sheu, M., & Lee, S. (2018). Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury. Oncotarget. https://doi.org/10.18632/oncotarget.25589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.